Hyperion Therapeutics logo

Hyperion Therapeutics

A biopharmaceutical company focused on developing treatments for urea cycle disorders and other rare diseases

3

Funding Rounds

$117.5m

Money raised

Overview

A biopharmaceutical company focused on developing treatments for urea cycle disorders and other rare diseases

Funding

Funding series

Funding Series Analysis

The company Hyperion Therapeutics has raised a total of $117.47m in funding over 3 rounds.

Key Insights:

  • Hyperion Therapeutics funding round, April 2011: $17.47m
  • Hyperion Therapeutics Series C round: $60m
  • Hyperion Therapeutics Series B round: $40m
Hyperion Therapeutics logo
Hyperion Therapeutics funding round, April 2011 $17.47m
Hyperion Therapeutics logo
Hyperion Therapeutics Series C round $60m
Hyperion Therapeutics logo
Hyperion Therapeutics Series B round $40m

Industries

Hyperion Therapeutics is active in the following industries: